These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. US Senate passes FDA Revitalization Act. Guthrie P CMAJ; 2007 Jul; 177(1):23. PubMed ID: 17606930 [No Abstract] [Full Text] [Related]
3. Postmarketing studies for approved human drug and licensed biological products; status reports. Food and Drug Administration, HHS. Final rule. Fed Regist; 2000 Oct; 65(210):64607-19. PubMed ID: 11503687 [TBL] [Abstract][Full Text] [Related]
4. PDUFA reauthorization--drug safety's golden moment of opportunity? Hennessy S; Strom BL N Engl J Med; 2007 Apr; 356(17):1703-4. PubMed ID: 17435082 [No Abstract] [Full Text] [Related]
5. Tempered enthusiasm. Drug-safety law needs more teeth, patient-safety advocates say. DerGurahian J Mod Healthc; 2007 Oct; 37(40):16. PubMed ID: 18018373 [No Abstract] [Full Text] [Related]
6. FDA attempting to overcome major roadblocks in monitoring drug safety. Zielinski SL J Natl Cancer Inst; 2005 Jun; 97(12):872-3. PubMed ID: 15956645 [No Abstract] [Full Text] [Related]
7. Today's FDA. Slater EE N Engl J Med; 2005 Jan; 352(3):293-7. PubMed ID: 15659733 [No Abstract] [Full Text] [Related]
8. Making medicines safer--the need for an independent drug safety board. Wood AJ; Stein CM; Woosley R N Engl J Med; 1998 Dec; 339(25):1851-4. PubMed ID: 9854125 [No Abstract] [Full Text] [Related]
9. FDA set to tighten guidelines on industry dissemination of information on unapproved uses of medical products. Lang L Gastroenterology; 2008 Apr; 134(4):905. PubMed ID: 18395067 [No Abstract] [Full Text] [Related]
10. Paying for drug approvals--who's using whom? Avorn J N Engl J Med; 2007 Apr; 356(17):1697-700. PubMed ID: 17435083 [No Abstract] [Full Text] [Related]
11. Devices and the food and drug administration. Phillips SJ; Phillips RS Artif Organs; 2005 May; 29(5):363-5. PubMed ID: 15854210 [No Abstract] [Full Text] [Related]
12. Drug approval system questioned in US and Canada. Eggertson L CMAJ; 2005 Feb; 172(3):317-8. PubMed ID: 15684107 [No Abstract] [Full Text] [Related]
13. Reforms on drug safety. Nature; 2006 Sep; 443(7110):372. PubMed ID: 17006474 [No Abstract] [Full Text] [Related]
14. Report hits FDA to revamp safety oversight. Finkelstein JB J Natl Cancer Inst; 2006 Jul; 98(13):884-5. PubMed ID: 16818849 [No Abstract] [Full Text] [Related]
15. The unfinished business of U.S. drug safety regulation. Evans BJ; Flockhart DA Food Drug Law J; 2006; 61(1):45-63. PubMed ID: 16838457 [No Abstract] [Full Text] [Related]
16. Reviving the FDA's Authority to Publicly Explain Why New Drug Applications Are Approved or Rejected. Herder M JAMA Intern Med; 2018 Aug; 178(8):1013-1014. PubMed ID: 29971404 [No Abstract] [Full Text] [Related]
17. Pin the tail on the other donkey: allocating and avoiding injury losses after drug or device approval. O'Reilly JT Food Drug Law J; 2007; 62(3):559-72. PubMed ID: 17915397 [No Abstract] [Full Text] [Related]
18. Comparative regulation of drug and aircraft development: lessons for regulatory reform? Urquhart J Clin Pharmacol Ther; 1997 Dec; 62(6):583-6. PubMed ID: 9433385 [No Abstract] [Full Text] [Related]
19. "Safer, but not safe enough". Crombie HD Conn Med; 2006; 70(10):645. PubMed ID: 17190395 [No Abstract] [Full Text] [Related]
20. Science and regulation. FDA's approach to regulation of products of nanotechnology. Hamburg MA Science; 2012 Apr; 336(6079):299-300. PubMed ID: 22517845 [No Abstract] [Full Text] [Related] [Next] [New Search]